-
Federal Circuit affirms district judge’s overruling of $469M jury verdict against DISH Network
Read more: Federal Circuit affirms district judge’s overruling of $469M jury verdict against DISH NetworkClearPlay sued DISH Network over its TV ad-skipping feature back in 2014, alleging infringement of two patents.
-
Power provider AES and partner Fluence targeted by non-practicing entity over patents relevant to clean energy distribution, storage
Read more: Power provider AES and partner Fluence targeted by non-practicing entity over patents relevant to clean energy distribution, storageGridScale Solutions LLC has sued the two companies in the U.S. District Court for the Eastern District of Virginia.
-
Milan Local Division grants Pirelli twin UPC wins, clarifies burden-shifting and claim construction in tire patent disputes
Read more: Milan Local Division grants Pirelli twin UPC wins, clarifies burden-shifting and claim construction in tire patent disputesThe Milan LD finds literal infringement of two Pirelli tyre patents, rejects a revocation counterclaim, and grants pan-UPC injunctions against two Chinese tire manufacturers.
-
USPTO denies ex parte reexam following earlier “settled expectations” refusal of inter partes review; Director defends discretionary powers before Federal Circuit
Read more: USPTO denies ex parte reexam following earlier “settled expectations” refusal of inter partes review; Director defends discretionary powers before Federal CircuitGeotab previously had its petition for IPR denied, at least on a partial basis of patent owner Fractus having settled expectations as per validity.
-
Huawei announces new semiconductor law: shows independence from Western chip supply
Read more: Huawei announces new semiconductor law: shows independence from Western chip supplyThe new principle, known as âthe Tau (Ď) Scaling Lawâ, has âprovenâ it can resolve global semiconductor and electronic system challenges, and Huawei âwelcomesâ peers in joining it in verifying the law, Huawei announced during the IEEE International Symposium on Circuits and Systems today.
-
Global pharma company Adalvo eying U.S. expansion, says Chief IP Officer
Read more: Global pharma company Adalvo eying U.S. expansion, says Chief IP OfficerWhile the B2B pharma company has expanded its European business significantly in the last decade, it is now turning to the U.S. to bring its licensing business, Adalvoâs Toni Santamaria told ip fray at IP Dealmakers earlier this month.
-
China Implements Pharmaceutical Test Data Protection Rules: A New Era for Drug Data Protection
Read more: China Implements Pharmaceutical Test Data Protection Rules: A New Era for Drug Data ProtectionChina has promulgated the Measures for the Implementation of Pharmaceutical Test Data Protection and the Work Scheme for Pharmaceutical Test Data Protection, which together operationalize for the first time a formal PTDP system in China, granting up to six years of data exclusivity to qualifying chemical and biological drug applicants.
-
Latest amendment to Tokyo District Court’s SEP rules: global license requirement compared to latest UPC, UK, German, Brazilian approaches
Read more: Latest amendment to Tokyo District Court’s SEP rules: global license requirement compared to latest UPC, UK, German, Brazilian approachesThe Tokyo court’s SEPJM approach is not what WIPO- pr PMAC-style mediation. But in ZTE v. Samsung, Western courts proposed settlement terms. Read our comparative analysis (premium) and general comments on reasonable discourse (free).
Follow Us
Latest Articles
- UPC Roundup (1 week): CoA reverses infringement ruling; extends evidence-production deadline over Chinese export controls; more
- UPC panels should state preliminary views at outset of every hearing: many practitioners are otherwise disinclined to file there
- Jury accepts “reverse doctrine of equivalents” defense in blood pump patent case involving Johnson & Johnson unit
- Rio court grants Dolby preliminary injunction in AV1 patent dispute against Skyworth
- Bill pending in Brazil’s Senate would add anti-interference (including anti-interim-license) provisions to patent law: draconian sanctions